Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Gel Use Disclosure in an Open-label 1% Tenofovir Gel Trial: Perspectives from Participants,Partners and Community Men in KwaZulu-Natal,South Africa